Clinical trial
Phase IIa of Tocilizumab In the Treatment of Polymyalgia Rheumatica
NCT01396317 is registered in ClinicalTrials.gov with Hospital for Special Surgery, New York as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase IIa of Tocilizumab In the Treatment of Polymyalgia Rheumatica
- Lead sponsor
- Hospital for Special Surgery, New York
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 2011
- Completion date
- January 31, 2016
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
polymyalgia rheumatica (pmr)